[EN] 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS [FR] 6-HÉTÉROARYLOXY BENZIMIDAZOLES ET AZABENZIMIDAZOLES EN TANT QU'INHIBITEURS DE JAK2
A tetrahydrofuran-compound is disclosed herein which is represented by the formula (1) ##STR1## wherein each of X.sub.1 and X.sub.2 is a hydrogen atom or a methyl group, Y is a hydrogen atom or a carbonyl group substituted by a lower alkyl group (Y') having 1 to 4 carbon atoms, i.e., an acyl group (--COY'), and n is 2 or 3, and an insecticide containing the tetrahydrofuran-compound as an effective component.
[EN] 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS<br/>[FR] 6-HÉTÉROARYLOXY BENZIMIDAZOLES ET AZABENZIMIDAZOLES EN TANT QU'INHIBITEURS DE JAK2
申请人:AJAX THERAPEUTICS INC
公开号:WO2021226261A1
公开(公告)日:2021-11-11
The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.
本公开提供了6-杂芳氧基苯并咪唑和氮杂苯并咪唑化合物及其组合物,用于抑制JAK2。
[EN] HETEROCYCLIC GLP-1 AGONISTS<br/>[FR] AGONISTES HÉTÉROCYCLIQUES DE GLP-1
申请人:GASHERBRUM BIO INC
公开号:WO2022028572A1
公开(公告)日:2022-02-10
This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.